Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li>Pharma company stocks is the only sector gaining in the weak market on Wednesday on optimism to sell anti-covid drugs approved by the drug regulator.</li><li>The pharma regulator gave approval to sell <keyword id="10880838" type="General" weightage="20" keywordseo="molnupiravir" source="Orion">Molnupiravir</keyword> drug, which is an anti-COVID pill, for emergency use in the country.</li><li><keyword id="44642" type="General" weightage="20" keywordseo="sun-pharma" source="Orion">Sun Pharma</keyword>, <keyword id="6357157" type="General" weightage="20" keywordseo="cipla" source="Orion">Cipla</keyword>, Torrent Pharma and <keyword id="4569824" type="General" weightage="20" keywordseo="strides-pharma" source="Orion">Strides Pharma</keyword> have already announced plans to launch their version of this pill soon amid rising spread of Omicron in the country.</li></ul>Pharmaceutical company stocks were the top gainers in a weak market on December 29 as the segment cheered pharma regulator’s — Drugs Controller General of India (DCGI) — approval of anti-covid pill for emergency use in the country. The move comes amid rising spread of Omicron cases in the country. Indian companies will manufacture a generic version of Merck's anti-COVID pill Molnupiravir in India. Molnupiravir is an antiviral medication that is used to treat COVID-19 in those infected. The drug was developed by US-based firms Merck and Ridgeback Biotherapeutics. The development has brought some optimism for pharma stocks that have been underperforming the market for more than a year. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Top performing pharma stocks on December 29 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">% of change </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">% returns in 2021 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Laurus Labs </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">2.38% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">53% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Dr Reddy’s Laboratories </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1.61% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-8% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Sun Pharmaceuticals </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1.58% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">38% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Lupin </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1.41% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-7% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Alembic Pharmaceuticals </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1.13% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-22% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Divi’s Laboratories </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1.67% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">19% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Cipla </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1.08% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">14% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Glenmark Pharmaceuticals </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1.07% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">3% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Natco Pharma </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-7% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Biocon </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">0.97% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-22% </td></tr></tbody></table> While Indian companies are manufacturing a generic version from US-based pill, they will market the pill under their respective brands and sell them in pharmacies and COVID-19 treatment centres. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Companies </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Anti-COVID pill </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Sun Pharmaceuticals </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Molxvir </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Torrent Pharmaceuticals </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Molnutor </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Cipla </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Cipmolnu </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Strides Pharma Science </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Stripiravir </td></tr></tbody></table>Earlier this year, US-based pharma company Merck had signed non-exclusive voluntary licensing agreements with over eight Indian companies to manufacture and supply generic versions of Molnupiravir in over 100 low and middle-income countries (LMICs), including India. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/the-ipo-excitement-may-be-softer-in-2022-but-that-can-be-a-good-thing-for-investors/articleshow/88557624.cms">The IPO excitement may be softer in 2022 but that can be a good thing for investors</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/startups/news/india-is-home-to-81-unicorns-now-as-mamaearth-globalbees-make-it-to-the-list/articleshow/88558418.cms">India is home to 81 unicorns now as Mamaearth, Globalbees make it to the list</a>

Sun Pharma, Dr Reddy’s Lab, Divi’s Lab and other pharma stocks rally on regulator’s nod to make anti-COVID pill

RIL, SBI, Lupin, Tech Mahindra and other buzzing stocks to watch out for on December 6

<ul><li>At 8:30 am, SGX Nifty was up by 50 points, or 0.37%. </li><li>Here’s a list of stocks to watch for in trade today. </li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider.</a> </li></ul>Indian stock markets could extend their gains on Monday after the Nifty crossed the 13,700 level on Thursday last week. At 8:30 am, SGX Nifty was up by 50 points, or 0.37%, suggesting that the Indian stock exchanges could have a positive start to the day. With the <a href="https://www.businessinsider.in/politics/world/news/trump-signs-bipartisan-coronavirus-relief-bill-after-calling-on-congress-to-approve-2000-stimulus-checks/articleshow/79984320.cms">Trump administration signing the $2,000 stimulus relief cheques</a> with bipartisan support, the US stock exchanges could bounce back. These are the stocks to watch out for during the trading session today: Reliance Industries Reliance Industries is all set to buy IMG Worldwide’s 50% stake in IMG-Reliance for ₹52.08 crore in a cash deal. IMG is a global sports, events, and talent management company. <keyword id="45383" type="DOMAIN" weightage="20" keywordseo="Coal-India">Coal India</keyword> The Maharatna public sector undertaking Coal India’s board has approved the company’s entry into aluminum and solar power sectors. Special purpose vehicles will be created in this regard. <keyword id="46698" type="DOMAIN" weightage="20" keywordseo="Lupin">Lupin</keyword> Lupin has received tentative approval from the US FDA for the generic version of Jublia solution. This solution is a prescription for treating toenail fungus. <keyword id="6362997" type="LOCATION" weightage="20" keywordseo="dlf">DLF</keyword> DLF Cyber City will acquire the stake of its partner Hines in One Horizon Center for ₹780 crore. The One Horizon Center is a 25-storied building located in Gurugram, Haryana. <keyword id="1350" type="CITY" weightage="20" keywordseo="Niit">NIIT</keyword> NIIT’s board has approved a share buyback proposal. Accordingly, the company will buyback shares worth ₹237 crore at a price of ₹240 per equity share. This is a premium of 20% compared to the closing price of ₹200.40 on December 24. Reliance Capital The troubled Reliance Capital has announced that it has defaulted on term loans from HDFC and Axis Bank. <keyword id="6362804" type="DOMAIN" weightage="20" keywordseo="cadila">Cadila</keyword> Healthcare Zydus Cadila Healthcare has announced that its COVID-19 vaccine, ZyCoV-D was found to be safe, well-tolerated during the Phase I and II clinical trials. It is now planning to begin Phase III trials with 30,000 volunteers after obtaining the required approvals. <keyword id="51758" type="DOMAIN" weightage="20" keywordseo="Dish-TV">Dish TV</keyword> Dish TV has received a demand notice from the government for the payment of license fee and interest to the tune of ₹4,164 crore. <keyword id="28423" type="DOMAIN" weightage="20" keywordseo="vedanta">Vedanta</keyword> Vedanta’s parent company, Vedanta Resources has increased its stake in the Indian unit to 55.11% by acquiring shares worth almost ₹3,000 crore from the open market. SEE ALSO: <a href="https://www.businessinsider.in/politics/world/news/trump-signs-bipartisan-coronavirus-relief-bill-after-calling-on-congress-to-approve-2000-stimulus-checks/articleshow/79984320.cms">Trump signs bipartisan coronavirus relief bill after calling on Congress to approve $2,000 stimulus checks</a> <a href="https://www.businessinsider.in/stock-market/news/new-fiscal-support-will-set-up-an-economic-boom-in-the-second-half-of-2021-evercore-analysts-say/articleshow/79978963.cms">New fiscal support will set up an economic boom in the second half of 2021, Evercore analysts say</a> <a href="https://www.businessinsider.in/stock-market/news/insiders-cash-out-via-ipos-as-investor-optimism-becomes-excessive-ndr-says/articleshow/79968643.cms">Insiders cash out via IPOs as investor optimism becomes excessive, NDR says</a>

Top stocks to watch – RIL, Coal India, Lupin, DLF, NIIT, Reliance Capital, Cadila Health, Dish TV, Vedanta, and others

<ul><li>At 7:45 am, SGX <keyword id="6354813" type="UNKNOWN" weightage="20" keywordseo="Nifty">Nifty</keyword> was up by 150 points, or over 1%.</li><li>Here’s a list of stocks to watch for in trade today.</li><li>Check out the latest news and updates on Business Insider.</li></ul>Indian stock markets could see a bounce back on Tuesday after the <a href="https://www.businessinsider.in/stock-market/news/sensex-sees-2-weeks-of-gain-wiped-out-in-half-a-day-plunges-by-over-1400-points/articleshow/79838339.cms">massive plunge on Monday</a>. At 7:45 am, SGX Nifty was up by 150 points, or over 1%, suggesting that the Indian stock exchanges will have a positive start to the day. This is despite the US stock exchanges <a href="https://www.businessinsider.in/stock-market/news/sp-500-slides-as-revived-lockdown-fears-offset-stimulus-progress/articleshow/79848110.cms">sliding over revived lockdown fears</a>. The Dow Jones barely closed in the green, up by 0.12%, while S&amp;P 500 was down by 0.39%. These are the stocks to watch out for during the trading session today: Airline stocks – <keyword id="6358032" type="DOMAIN" weightage="20" keywordseo="SpiceJet">SpiceJet</keyword>, <keyword id="2351966" type="COMPANY" weightage="20" keywordseo="InterGlobe-Aviation">InterGlobe Aviation</keyword> With India suspending flights to the UK till December 31, airline stocks SpiceJet and InterGlobe Aviation will be in the focus. While SpiceJet fell by 10% yesterday, InterGlobe Aviation fell by 9.39%. Hotel stocks – Indian Hotel, Kamat Hotels The Maharashtra government announced night curfew from December 22 to January 5. This brings hotel stocks such as Indian Hotel, Kamat Hotels, and The Oberoi Group’s EIH under focus in trade today. <keyword id="42747" type="DOMAIN" weightage="20" keywordseo="Tata-Motors">Tata Motors</keyword> The company announced that it is increasing prices of commercial vehicles from January 1 due to an increase in input cost and the impact of forex rates. <keyword id="44612" type="DOMAIN" weightage="20" keywordseo="Pfizer">Pfizer</keyword> Pfizer has received approval from the European Medicines Agency for the BioNTech COVID vaccine in the European Union. <keyword id="46698" type="DOMAIN" weightage="20" keywordseo="Lupin">Lupin</keyword> Lupin received US FDA approval for its Banzel oral suspension. Majesco Edelweiss Retail Finance has acquired 2.04 lakh shares of the company at ₹974 per share. <keyword id="106317" type="DOMAIN" weightage="20" keywordseo="Asian-Paints">Asian Paints</keyword> The company’s promoter entity Smiti Holding and Trading Company has released a pledge on 9 lakh shares. <keyword id="1350" type="CITY" weightage="20" keywordseo="Niit">NIIT</keyword> The company’s board is meeting on December 24 to consider share buyback. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/sensex-sees-2-weeks-of-gain-wiped-out-in-half-a-day-plunges-by-over-1400-points/articleshow/79838339.cms">Sensex sees 2 weeks of gain wiped out in half a day – plunges by over 1,400 points</a> <a href="https://www.businessinsider.in/india/news/india-suspends-all-flights-from-uk-until-december-31-as-a-new-covid-19-strain-emerges/articleshow/79838835.cms">India suspends all flights from UK until December 31 as a new COVID-19 strain emerges</a>

Top stocks to watch – SpiceJet, InterGlobe Aviation, Tata Motors, Pfizer, Asian Paints, NIIT, Lupin, and others

<ul><li>The US stock markets soared on Tuesday, as investors eagerly awaited the results of US 2020 presidential elections.</li><li>SGX Nifty was trading 0.34% lower at 7:48 am, indicating a tepid start for Nifty50. </li><li>Here’s a list of stocks to watch for in trade today. </li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider. </a></li></ul>Amidst mixed cues from the global markets, the Indian equities are likely to open flat on Wednesday. The SGX Nifty was trading 0.34% lower at 7:48 am, indicating a tepid start for Nifty50. However, the US stock markets soared on Tuesday, as investors eagerly awaited the results of 2020 US presidential elections. The Dow Jones Industrial Average gained over 554 points, and the S&amp;P 500 gained 1.78%. These are the stocks to watch out for during the trading session on November 4: <keyword id="407979" type="COMPANY" weightage="20" keywordseo="Ajanta-Pharma">Ajanta Pharma</keyword> In a meeting held on November 3, Ajanta Pharma’s board approved the proposal to buyback its fully paid-up 7.35 lakh equity shares at a price of ₹1,850 each for an aggregate consideration not exceeding ₹135.97 crore. The shares of Ajanta Pharma ended 3% higher on Tuesday. Somany Home Innovation HDFC MF has reduced its stake in the company to 4.67% from 6.68% on October 30. The shares of Somany Home Innovation ended 1% higher on Tuesday. <keyword id="799" type="CITY" weightage="20" keywordseo="PVR">PVR</keyword> Leading multiplex chain operator PVR reported a consolidated net loss of ₹184.06 crore for the second quarter ended September 30, against the net profit of ₹47.67 crore in the same quarter last year. The total income of the company declined to ₹110.61 crore during the quarter under review as against ₹979.40 crore in the corresponding quarter last fiscal year. The shares of PVR ended 0.23% higher on Tuesday. HLE Glascoat Malabar India Fund will acquire 1.44 lakh shares of HLE Glascoat at ₹1,385 per share, aggregating up to ₹20 crore and 5.78 lakh warrants at ₹1,385 per warrant, aggregating up to ₹80 crore. The shares of HLE Glascoat ended 0.65% higher on Tuesday. <keyword id="141201" type="COMPANY" weightage="20" keywordseo="Cera-Sanitaryware">Cera Sanitaryware</keyword> Cera Sanitaryware informed stock exchanges that production at the sanitaryware unit continues to be partially affected due to unrest at its Mehsana facility. The shares of Cera Sanitaryware ended 0.13% lower on Tuesday. ICICI Lombard General Insurance ICICI Lombard General Insurance said it received no adverse observation letter from exchanges regarding the acquisition of Bharti Axa General Insurance. The shares of ICICI Lombard General Insurance ended 0.14% higher on Tuesday. <keyword id="886211" type="ORGANIZATION" weightage="20" keywordseo="Adani-Gas">Adani Gas</keyword> Adani Gas reported a record net profit in the September quarter as sales returned to pre-Covid levels quicker than anticipated. Net profit in July-September quarter at ₹136 crore was 13% higher compared to the profit a year ago. The shares of Adani Gas ended 2% higher on Tuesday. State Bank of India, <keyword id="46698" type="CITY" weightage="20" keywordseo="Lupin">Lupin</keyword>, HPCL and Adani Enterprises State Bank of India, Lupin, HPCL, Adani Enterprise are slated to announce their quarterly results today. SEE ALSO: <a href="https://www.businessinsider.in/politics/world/news/2020-election-see-insiders-comprehensive-guide-to-the-presidential-and-top-congressional-races/articleshow/78878848.cms" data-type="tilCustomLink">LIVE RESULTS: 2020 presidential and key congressional races</a> <a href="https://www.businessinsider.in/business/news/jack-ma-ant-group-ipo-listing-has-been-suspended-by-the-shanghai-stock-exchange/articleshow/79022502.cms" data-type="tilCustomLink">China suspends Jack Ma’s $34 billion Ant Group listing — citing changes in regulatory environment</a>

Top stocks to watch — SBI, Ajanta Pharma, PVR, Lupin, Adani Gas, Cera Sanitaryware, and others

<ul><li>At 7:49 am, the SGX Nifty was trading 0.98% higher, indicating a positive start for Nifty50. </li><li>Here’s a list of stocks to watch for in trade today. </li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider. </a></li></ul>Amidst positive cues from the global market, the Indian stock market is likely to open higher. At 7:49 am, the SGX Nifty was trading up 0.98%, indicating a green start for Nifty50. The US stocks also ended in the green on Wednesday on the back of further stimulus hopes. The Dow Jones Industrial Average closed 1.20% higher; whereas the S&amp;P 500 was down 28 points on Wednesday. These are the stocks to watch out for during the trading session on October 1: Reliance Industries (RIL) Mukesh Ambani’s owned Reliance Retail Ventures Limited has<a href="https://www.businessinsider.in/business/news/reliance-retail-raises-another-1875-crore-as-silver-lake-comes-back-with-an-additional-investment/articleshow/78412992.cms"> raised ₹1,875 crore </a>from Silver Lake co-investors. The shares of RIL ended 0.49% lower yesterday Oil and Natural Gas Corp, GAIL India, Oil India and other natural gas stocks The stocks of natural gas companies will be in focus today as the Indian government slashed the rate by 25% to $1.79 for the period of October 2020 to March 2021. This is the price at which most of the natural gas produced in India is sold. The shares of Oil and Natural Gas Corp and GAIL Limited ended 2% lower yesterday, whereas Oil India was up nearly 2%. Also watch out for IGL, MGL and Gujarat Gas. Inox Leisure and PVR Limited As part of the unlock 5.0 guidelines, the Ministry of Home Affairs (MHA) has allowed reopening of cinema halls from October 15. The stock of Inox Leisure and PVR Limited will be in focus today during the trade. The shares of Inox Leisure and PVR LImited ended 2% higher yesterday. Lupin The drug major Lupin launched Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer, in the US market. The company has launched Lapatinib tablets in the strength of 250 mg after its alliance partner Natco Pharma received final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration (USFDA), it said in a statement. The shares of Lupin ended 0.8% higher yesterday. Sanofi India Sanofi India on Wednesday launched a booster vaccine for preschoolers to protect against four major diseases - diphtheria, pertussis, tetanus and polio. “Booster vaccines are designed to boost the immunity acquired during prior vaccination,” the company said. The shares of Sanofi India ended 1.4% higher yesterday. Dhanlaxmi Bank Shareholders of Dhanlaxmi Bank ousted chief Sunil Gurbaxani, little over seven months after he assumed charge of the lender. This came a day after the Reserve Bank of India appointed its General Manager D K Kashyap on the board of the bank for two years. The shares of Dhanlaxmi Bank ended 1% lower yesterday. Punjab National Bank The state-run public sector bank Punjab National Bank (PNB) declared its ₹1,203.26 crore exposure to Sintex Industries as a fraud. The shares of Punjab National Bank ended 2% lower yesterday. HDFC Limited The National Housing Bank imposed a monetary penalty of ₹1.5 lakh on HDFC Limited for non-compliance of the housing finance companies directions. The shares of HDFC Limited ended 1.16% higher yesterday. Bank of Baroda The state-run Bank of Baroda has dissolved its wholly-owned arm BOB (UK) in the United Kingdom with effect from September 22. The shares of Bank of Baroda ended 0.85% lower yesterday. Auto stocks in focus today Watch out for the likes of Maruti, Tata Motors and other listed auto stocks as they report their monthly sales for September. The <a href="https://www.businessinsider.in/business/auto/news/cars-and-tractor-sales-likely-to-remain-healthy-but-commercial-vehicles-may-feel-the-pain-in-september-month-sale/articleshow/78407001.cms">estimates from brokerages</a> showed that passenger vehicles and farm equipment would report strong growth. However, the situation for the commercial vehicle segment will continue to remain grim. Mazagon Dock, Likhitha Infrastructure and UTI AMC The IPO subscription for Mazagon Dock, Likhitha Infrastructure and UTI AMC will close today. CAMS, Chemcon <a href="https://www.businessinsider.in/stock-market/news/cams-ipo-shares-are-trading-at-over-25-premium-in-the-grey-market/articleshow/78400317.cms">CAMS </a>and <a href="https://www.businessinsider.in/stock-market/news/grey-market-premium-for-chemcon-ipo-share-price-trading-at-over-111/articleshow/78404223.cms">Chemcon shares </a>are slated to hit the bourses today. The grey market premium for the companies suggests a bumper listing ahead. SEE ALSO: <a href="https://www.businessinsider.in/india/news/from-income-tax-to-credit-card-payment-here-are-all-the-rules-changing-from-october-1/articleshow/78418580.cms" data-type="tilCustomLink">From income tax to credit card payment - here are all the rules changing from October 1</a> <a href="https://www.businessinsider.in/business/auto/news/cars-and-tractor-sales-likely-to-remain-healthy-but-commercial-vehicles-may-feel-the-pain-in-september-month-sale/articleshow/78407001.cms" data-type="tilCustomLink">All eyes on September auto sales — Cars and tractor sales likely to remain healthy but commercial vehicles may feel the pain</a> <a href="https://www.businessinsider.in/business/auto/news/hero-motocorp-expected-to-outperform-bajaj-auto-and-tvs-sales-numbers-in-september-two-wheeler-sales/articleshow/78407559.cms?upcache=2" data-type="tilCustomLink">September two-wheeler sales expectations — Hero MotoCorp expected to outperform Bajaj Auto and TVS Motor</a>

Top stocks to watch— RIL, ONGC, HDFC, GAIL, PVR, Oil India, Lupin, PNB, Dhanlaxmi Bank and others

<ul><li>The Nifty Pharma index gained 2.82% during the early trading hour.</li><li>These were the top gainers in the Nifty Pharma pack.</li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider.</a> </li></ul>The Nifty Pharma index gained 2.82% during the early trading hour. Pharma stocks have been on a roll over the past few days. Nifty Pharma index was trading 382.50 points higher, while the Nifty 50 index was up 44 points at 9:30 am. These were the top gainers in the Nifty Pharma pack: Lupin gained 7%, and Cipla was up 5% The shares of Lupin Limited gained 7%, and Cipla was trading 5% higher during the trade on September 18. The jump in the shares of the pharma companies came after its Irish-peer Perrigo voluntarily recalled albuterol inhalation. This development bodes well for Lupin and Cipla. Cipla launched gProventil in April this year, and Lupin’s gProAir is expected to be launched this month. Dr Reddy’s Laboratories gains 4% Dr.Reddy’s Laboratories was the third-largest gainer in the Nifty pharma pack, trading almost 4% higher. The company has announced a settlement of litigation with a unit of Bristol Myers Squibb related to patents for Revlimid (lenalidomide) capsules, used to treat various kinds of cancer. “We are pleased with the settlement agreement, and look forward to bringing a generic version of lenalidomide to market soon subject to regulatory approval for the benefit of patients,” Dr Reddy’s Laboratories North America Generics CEO Marc Kikuchi said. Other pharma stocks surge in trade as well Other pharma were also trading higher fueled by the rally in the pharma sector. Sun Pharma, Divi’s Laboratories, Aurobindo Pharma and Torrent Pharmaceuticals are all up over 2%. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/top-stocks-to-watch-dr-reddys-laboratories-hdfc-bank-tvs-motor-vedanta-irctc-lt-bharat-forge-hal-and-more/articleshow/78179393.cms" data-type="tilCustomLink">Top stocks to watch— Dr Reddy's Laboratories, HDFC Bank, TVS Motor, Vedanta, IRCTC, L&amp;T, Bharat Forge, HAL, and more</a> <a href="https://www.businessinsider.in/sports/news/dailyhunt-app-founders-confirm-ipl-2020-associate-sponsorship/articleshow/78169667.cms" data-type="tilCustomLink">EXCLUSIVE: Dailyhunt founders confirm IPL 2020 associate sponsorship — promise new release for Josh ahead of India’s biggest cricket tournament</a>

Top pharma stock movers — Lupin, Cipla, Dr Reddy’s steal the show

22 foreign-language shows you should be watching on Netflix

<ul><li>Indian pharmaceutical company <keyword id="46698" type="CITY" weightage="20" keywordseo="Lupin">Lupin</keyword> has confirmed an ‘information security incident’ that has affected multiple internal systems.</li><li>The incident comes within weeks of a ransomware attack on Dr Reddy’s Laboratories. </li><li>The average cost of a data breach in the healthcare industry is $7.3 million — 84% higher than the global average across all sectors.</li></ul>Another leading Indian pharmaceutical, Lupin, has reported a cybersecurity attack on its IT systems within two weeks of a ransomware attack on Dr Reddy’s Laboratories. “We have recently experienced an information security incident that has affected several of our internal IT systems. This has not impacted our core systems and operations,” Lupin told <a href="https://www.thehindubusinessline.com/companies/lupin-confirms-security-incident-days-after-dr-reddys-cyber-attack/article33029527.ece">Hindu Business Line</a> in a statement. In October, Dr Reddy’s Laboratories had to ‘isolate’ its servers and took ‘preventive actions’ in the wake of a ransomware attack. The attack also <a href="https://www.businessinsider.in/india/news/dr-reddys-shares-fell-over-3-the-drug-maker-isolated-all-data-service-centers-after-a-cyber-attack/articleshow/78806238.cms">reportedly</a> forced the company to shut down its manufacturing facilities across the world to minimise the attack’s impact. The incidence of hackers trying to breach the firewalls of the healthcare industry have only increased during the coronavirus pandemic.To be fair, the Indian healthcare industry isn’t particularly careful about connecting to the internet. For instance, in June, the CEO of Hackrew and IIT Guwahati graduate <a href="https://medium.com/bugbountywriteup/how-screwed-is-indian-healthcare-data-fa4584be8a04">Sai Krishna Kothapalli</a> was able to view, edit and delete classified personal information of lakhs of patients all over India. Healthcare industry faces the most expensive data breaches “Financially motivated criminal groups continue to target this industry via ransomware attacks,” said Verizon’s annual Data Breach Investigations Report 2020. To make matters worse, the average cost of a <keyword id="10183471" type="UNKNOWN" weightage="20" keywordseo="cybersecurity-breach">cybersecurity breach</keyword> in the healthcare industry is higher than any other sector at a whopping $7.3 million. <div type="image" title="Average total cost of a data breach by industry (1)" msid="79061658" hostid="261" caption="&amp;lt;p&amp;gt;Average total cost of a data breach by industry&amp;lt;/p&amp;gt;"></div> Even though this figure varies across geographies, the average cost of a <keyword id="10226939" type="UNKNOWN" weightage="20" keywordseo="data-breach-in-healthcare">data breach in healthcare</keyword> has been the most expensive for over a decade, according to <a href="https://www.ibm.com/in-en/security/data-breach">IBM’s Cost of a Data Breach 2020</a> report. This year was a 10% increase over 2019 and 84% higher than the global average. Healthcare industry takes nearly a year to track down cybersecurity issues While some data breaches can be attributed to human error or a system glitch, already 50% of them in the healthcare sector are due to malicious attacks. The healthcare industry also takes the longest amount of time to detect a breach and then contain the attack. IBM pegs the average time to around 329 days — that’s nearly a full year of data being exposed. <div type="image" title="Average time to identify and contain a data breach by industry" msid="79061682" hostid="261" caption="&amp;lt;p&amp;gt;Average time to identify and contain a data breach by industry&amp;lt;/p&amp;gt;"></div> However, India is not alone in its struggle. Other countries around the world are also grappling with the new onslaught of cyberattacks in the healthcare sector. Germany, for example, is trying to get ahead of the curve by enacting a new law for patient data protection and increased digitisation in health. In July, it already <a href="https://www.insideprivacy.com/health-privacy/germany-prepares-new-law-for-patient-data-protection-and-increased-digitalisation-in-healthcare-and-for-data-donations-for-research-purposes/">passed the draft bill</a> and is expected to come into force before the end of the year. SEE ALSO: <a href="https://www.businessinsider.in/defense/news/india-is-willing-to-challenge-the-status-quo-says-defence-minister-while-outlining-the-four-core-principles-behind-the-countrys-security-policy/articleshow/79059040.cms">India is willing to challenge the status quo and protect against ‘unilateralism and aggression,’ says Defence Minister Rajnath Singh</a> <a href="https://www.businessinsider.in/science/environment/news/india-demands-environment-friendly-technology-to-be-made-available-at-affordable-prices-to-battle-climate-change/articleshow/79056886.cms">India demands environment-friendly technology to be made available at affordable prices to battle climate change</a> <a href="https://www.businessinsider.in/finance/banks/news/rbi-and-indian-banks-wait-as-supreme-court-adjourns-loan-moratorium-hearing-to-november-18/articleshow/79057919.cms">RBI and banks caught in the crosshairs as the Supreme Court adjourns loan moratorium hearing for a second time to November 18</a>

Another Indian pharmaceutical giant reports cybersecurity breach within two weeks of ransomware hack on Dr Reddy’s

The top 9 shows on Netflix this week, from 'Manifest' to 'Lupin'

<ul class="summary-list"><li>Part 2 of "<keyword id="46698" type="CITY" weightage="60" keywordseo="Lupin">Lupin</keyword>" ends with a twist-filled episode packed with suspense and disguises.</li><li>Series cocreator George Kay said that the third part will be "a new adventure entirely."</li><li>"Lupin" is one of the most-watched shows on <keyword id="128682" type="COMPANY" weightage="60" keywordseo="Netflix">Netflix</keyword>, The Hollywood Reporter wrote in April.</li></ul>Warning: This post contains major spoilers for Part 2 of "Lupin." The second part of <a href="https://www.insider.com/best-netflix-original-tv-shows-ranked-2021">Netflix thriller "Lupin"</a> ends with a breathless chase through a sprawling auditorium, several very convincing disguises, and enough loose ends for an entertaining third season. "Lupin" follows suave conman <a href="https://www.insider.com/omar-sy-ignored-paris-subway-station-putting-up-lupin-posters-2021-6">Assane Diop (played by Omar Sy)</a> as he tries to take revenge against those who framed his late father, Babakar (played by Fargass Assandé), for stealing a priceless diamond necklace. Through his many heists to clear his father's name, <a href="https://time.com/6071968/lupin-omar-sy-interview/">Assane takes inspiration from Arsène Lupin</a>, a character created by real-life French novelist Maurice LeBlanc.In the five-episode Part 1 released in January, "Lupin" gave viewers a peek into its enigmatic main character's life and that of the people who wronged his family. Assane comes close to exposing his father's former boss Hubert Pellegrini (played by Hervé Pierre) for pinning the theft of the diamond necklace on Babakar, as well as some other suspicious deals. However, the wealthy businessman uses his connections in the media to avoid being held accountable. The second part, which started streaming on Netflix on Friday, continues to follow Assane on his journey to seek long-overdue justice. He has more success in exposing Hubert and his accomplices this time around.In the final scene of the fifth episode (the last installment of Part 2), Assane tells his family, "I'll be back" before disappearing into the night as police sirens blare in the background.Luckily, "Lupin" fans won't have to wait too long after this big cliffhanger to find out if the story will continue - Netflix renewed the popular <keyword id="36507" type="ENTERTAINMENT" weightage="60" keywordseo="Thriller">thriller</keyword> for <a href="https://www.bustle.com/entertainment/lupin-part-3-premiere-date-cast-plot-details">a third batch of episodes in May</a>. Sy also confirmed the news in a tweet. A release date for Part 3 of "Lupin" hasn't been announced yet.<h2>'Lupin' Part 2 ends at a crucial time in Assane's story</h2>In the first two parts, "Lupin" reveals that Babakar is innocent and that Hubert fraudulently claimed that the diamond necklace was stolen so the businessman could cash in on the insurance money. Babakar was found dead by suicide in jail in the first part, but viewers find out in the second installment that Hubert actually had Babakar killed to silence him, staging it as a suicide. The second part ends with Hubert under arrest in connection with embezzling money and having Babakar and journalist Fabienne Bériot (played by Anne Benoît) killed.While it's a promising start at justice, it's still not guaranteed that Hubert will actually face any consequences for his crimes. In the fourth episode of the second part, Hubert is brought into the police station for questioning for insurance fraud related to the diamond necklace, but he uses his connections to avoid having to reveal anything. Similarly, while Hubert may or may not finally be brought to justice, Assane is still wanted for many crimes, including stealing the infamous diamond necklace from an auction months prior. Not much is known about his whereabouts at the end of the second part. Hopefully, the next batch of episodes will give viewers some answers about that.<div type="image" title="lupin netflix" height="1101" width="1468" msid="83519962" hostid="261"></div>"Lupin" cocreator George Kay said during a June 4 appearance on <a href="https://www.hollywoodreporter.com/tv/tv-news/tvs-top-5-lupin-part-2-we-are-lady-parts-rise-of-global-tv-1234962746/">The Hollywood Reporter's "TV's Top 5" podcast</a> that while the first two parts of the stylish show are all about "the avenging of Babakar's death," part three will be "a new adventure" featuring Assane. "Part 3 will be a new adventure entirely with a new emotional goal and a similar amount of adventures and self-contained stories to kind of get us across that arc," Kay told podcast hosts Lesley Goldberg and Daniel Fienberg. "So, yeah, similar, but moving on from the kind of central arc of one and two."It's not a surprise that Netflix wants to continue exploring the world "Lupin" has created - the show is <a href="https://www.businessinsider.com/lupin-one-of-netflix-biggest-hits-all-time-viewership-data-2021-1">one of the most popular series</a> on the streaming platform. The Hollywood Reporter <a href="https://www.hollywoodreporter.com/tv/tv-news/lupin-netflix-viewership-1st-quarter-2021-4169497/">wrote in April</a> that the series, which holds a <a href="https://www.rottentomatoes.com/tv/lupin">98% approval rating on Rotten Tomatoes</a>, was the most-watched Netflix show in the first quarter of 2021. Seventy-six million viewers watched at least some of the thriller's first part, the streaming platform told THR.

You Searched For "Lupin" and got 11 results

Sun Pharma, Dr Reddy’s Lab, Divi’s Lab and other pharma stocks rally on regulator’s nod to make anti-COVID pill

Bhakti Makwana

RIL, SBI, Lupin, Tech Mahindra and other buzzing stocks to watch out for on December 6

Bhakti Makwana

Top stocks to watch – RIL, Coal India, Lupin, DLF, NIIT, Reliance Capital, Cadila Health, Dish TV, Vedanta, and others

Rounak Jain

Top stocks to watch – SpiceJet, InterGlobe Aviation, Tata Motors, Pfizer, Asian Paints, NIIT, Lupin, and others

Rounak Jain

Top stocks to watch — SBI, Ajanta Pharma, PVR, Lupin, Adani Gas, Cera Sanitaryware, and others

Navdeep Yadav

Top stocks to watch— RIL, ONGC, HDFC, GAIL, PVR, Oil India, Lupin, PNB, Dhanlaxmi Bank and others

Navdeep Yadav

Top pharma stock movers — Lupin, Cipla, Dr Reddy’s steal the show

Navdeep Yadav

22 foreign-language shows you should be watching on Netflix

Gabbi Shaw

Another Indian pharmaceutical giant reports cybersecurity breach within two weeks of ransomware hack on Dr Reddy’s

Prabhjote Gill

The top 9 shows on Netflix this week, from 'Manifest' to 'Lupin'

Travis Clark

Netflix's smash hit 'Lupin' ends Part 2 with a twist-filled episode - and enough loose ends for another season

Debanjali Bose

Popular Keywords

Buying Guides